Sector: Health Care
Director information for CONMED CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Andrew Moller | Interim Principal Financial Officer | 51 | ["Interim principal financial officer at CONMED Corporation since March 2026","VP, Corporate Controller at CONMED Corporation since 2025","Global Controller and CFO Asia-Pacific at Smith & Nephew PLC from 2019 to 2024","Various finance and audit positions at Stanley Black & Decker, Inc.","Various finance and audit positions at Coca-Cola Company","Auditor at Ernst & Young LLP","Master of International Business Studies from University of South Carolina","Bachelor of Science in Business Administration from College of Charleston","Certified Public Accountant"] | [] | 2026 |
| Barbara J. Schwarzentraub | 60 | ["Formerly served in various senior leadership and finance roles at Caterpillar from 1990 to 2020, including Director and Divisional CFO for the Global Information Services Division and Director of Global Component Manufacturing and Supply Chain.","extensive global experience in information technology and supply chain management","leading large organizations","finance and accounting","audit committee financial expert under SEC rules","significant finance and accounting expertise"] | ["C"] | 2026 | |
| Chair of Medicinal Genomics | Chair | [] | [] | 2026 | |
| Chair of Medzown | Chair | [] | [] | 2026 | |
| Chair of Wellist | Chair | [] | [] | 2026 | |
| Charles M. Farkas | 74 | ["Former executive at Bain & Company (1979 - 2026), including most recently as Senior Partner.","45+ years working in healthcare and medical technology.","more than 40 years working in the healthcare and medical technology fields in the U.S. and around the world","provides the Board with valuable strategic and governance perspectives","vast experience inside and outside the healthcare industry"] | ["C"] | 2026 | |
| David Bronson | 72 | ["Former Executive VP and CFO of PSS World Medical from 2002 - 2013.","Former CFO of Digineer and VWR Scientific Products.","substantial experience as a Chief Financial Officer","financial and accounting expertise","experience in the healthcare industry","audit committee financial expert"] | [] | 2026 | |
| Hollie Foust | EVP, General Counsel and Corporate Secretary; Executive Vice President, General Counsel and Corporate Secretary | 51 | ["EVP, General Counsel and Corporate Secretary at CONMED Corporation","SVP, Deputy General Counsel at Cardinal Health, Inc.","Various legal roles at Abbott Laboratories","Focused on banking and financing transactions at Bailey Cavalieri LLC"] | ["Integrity and Compliance Committee"] | 2026 |
| Kim Kelderman | President and CEO and Director | 58 | ["President and CEO and Director at Bio-Techne since 2024.","Previously served as Chief Operating Officer and President of Diagnostics and Genomics.","Formerly served in various senior leadership roles at Thermo Fisher Scientific and Becton, Dickinson and Co.","extensive global leadership experience across large and mid-cap life sciences businesses","strong track record in global operations, innovation and strategy","executive management experience","expertise leading the growth of biotechnology companies"] | [] | 2026 |
| LaVerne H. Council | Chair of the Board | 64 | ["CEO of Emerald One since 2019.","Former National Managing Principal, Enterprise Technology Strategy & Innovation for Grant Thornton.","Formerly served in various executive and other positions for MITRE Corporation, United States Department of Veterans Affairs, Council Advisory Services, Johnson & Johnson and Dell.","extensive experience as a global operations and information technology executive","experience managing budgets up to $4.5 billion per year","significant public company board and board committee experience","expertise and perspectives to guide the Board"] | ["C"] | 2026 |
| Mark Kaye | Executive VP and CFO | 46 | ["Executive VP and CFO of Elevance Health since 2023.","Formerly served in various executive and finance positions for Moody’s, Massachusetts Mutual Life Insurance Company, Voya Financial, ING U.S. and ING Groep, N.V. and Credit Suisse First Boston."] | [] | 2026 |
| Patrick J. Beyer | President and CEO and Director; President and Chief Executive Officer | 60 | ["Former positions held with the Company since 2014 include Chief Operating Officer, President of International and Global Orthopedics, and President of CONMED International.","President and Chief Executive Officer of CONMED Corporation since 2025","Chief Operating Officer of CONMED Corporation in 2024","President of International and Global Orthopedics at CONMED Corporation from 2020 to 2024","Chief Executive Officer of ICNet from 2010 to 2014","President of Stryker EMEA from 2009 to 2010","Various positions in general management from 1997 to 2005"] | ["Audit and Risk Committee"] | 2026 |
| Scott Rosen | President and Chief Executive Officer | ["President and Chief Executive Officer of CONMED Corporation since 2025","Chief Operating Officer of CONMED Corporation in 2024","President of International and Global Orthopedics at CONMED from 2020 to 2024","President of CONMED International from 2014 to 2020","Chief Executive Officer at ICNet from 2010 to 2014","President of Stryker EMEA from 2009 to 2010","VP Sales and Marketing at Stryker Europe from 2005 to 2009","Various prior positions in general management from 1997 to 2001","Board member at Bioventus Inc. since 2021"] | ["Audit and Risk Committee"] | 2026 |
